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Origin and primary structure of CLPs
Cyclic lipodepsipeptides (CLPs) are secondary metabolites
typically produced by Pseudomonas and Bacillus bacterial species
via non ribosomal pathways [1]. These biomolecules are
constituted of a fatty acid moiety linked to the N-terminus of a
peptide chain which is cyclized by an ester (or depsi) bond
formation between its C-terminus and a hydroxyl group capped
side chain of a Ser or Thr residue. Due to the nature of the
biosynthesis, the familiar prevalence of L-amino acids is flawed by
the significant presence of residues maintaining D-configuration.
The CLPs are classified depending on the length of the peptide
chain and on the size of the cycle. Herein, the eponym members
of viscosins, orfamides, xantholyisins and amphisins will be
scrutinized (Fig. 1). It is apparent that the alternation of amino
acids with polar and apolar side chain is a common feature. Is
their order random or purposeful? Figure 1: The primary structures of the presented CLPs. The fatty acid parts (3-HDA = (R)-3-hydroxydecanoic acid and 3-HTDA = (R)-3-hydroxytetradecanoic acid 
are highlighted by grey, while the amino acid residues are colored according to the polarity of their side chain, i.e. hydrophilic = red, hydrophobic = green. 
Why CLPs? What are we looking for?
CLPs possess a wide range of biological activites: their antifungal, antiviral, anticancer and antibacterial effects [1–3] have already been exploited e.g. in the field of
crop protection [4]. More importantly, CLPs provide either of the two classes of antibiotics that have been approved for clinical use in the past 30 years [5].
The level of bioactivity depends on the mode of action that is inherently determined by the structures of the chosen agent and its target. In case of CLPs the
molecular background of the function is not well understood. To start with, the conformation of cyclic lipodepsipeptides is yet poorly explored (the tertiary structure
is available for less than 10% of the already identified ~100 CLPs). Thus, an intention of this study is to present and correlate the previously unknown solution
conformation of viscosin A, orfamide B and xantholysin A. Moreover, the effect of gradual ring size extension can be studied systematically by involving amphisin (Fig.
1) in the analysis. Such structural comparison spanned over distinct CLP subgroups might lead us to realize the principle behind the design of natural cyclic
lipodepsipeptides which could be a milestone on the path towards the development of novel efficient pharmaceuticals.
How?
The peptides were biosynthetized by Pseudomonas strains and
submitted for HPLC purification afterwards (both conducted locally,
at UGent). To gain insight to the conformation at atomic resolution,
solution state NMR spectroscopy was applied for collecting 1H–1H
distances. This data was used as a set of distance restraints which
aided the silico structure determination performed by molecular
dynamics simulations using the force fields of the CNS 1.21 [6] and
AMBER14 software packages [7] (Fig. 2).
Results – Tertiary structure
The three-dimensional structures of the four CLP family representatives are built from the same elements: an αL-
helix kicks off from Leu1 and penetrates up to the 4th endocyclic residue (Fig. 2). From then on, it proceeds into loop
which connects the C-terminal with an OH-capped side chain via a depsi bond. This means that the length of the αL-helix
stays the same for viscosin A, orfamide B and amphisin (involving 6 residues for each) and the extension of the ring
influences the loop size and conformation. The latter is varying in order to maintain the perfect separation of the
hydrophobic and hydrophilic side chains what was already established by the helical motif and present for all cyclic
lipopeptides in question. On the other hand, orfamide B and xantholysin A bear the same ring arrangement in terms of
the side chain polarity in the respective positions. As a result, their ring and loop conformation are identical. The four
extra exocyclic residues for xantholysin A simply prolong the amphipathic αL-helix with an additional turn opposed to
orfamide B. Along with the three-dimensional structures of cyclic lipopeptides containing non-natural amino acids
[tolaasins: 2, syringomicins: 9], the herein presented observations confirm the preservation of the amphipathic character
to be a fundamental driving force for the construction of natural CLPs.
1
1
1
Future prospects – Mode of action
Concomitantly, the insertion of the amphipathic cyclic lipopeptides in apolar solvent triggers their self-assembly. The
phenomenon was examined in detail for pseudodesmin A (member of viscosins) which pointed out the occurence of
tubular-shaped associations (Fig. 3) [10]. A familiar explanation for the mechanism of action of antimicrobial peptides is
the creation of such pore-like associations which disrupt the plasma membrane and cause the lysis of the cell [11].
Obviously, investigating the bioagent alone does not allow to make general assumptions, since the actual process
depends on the chosen target as well.
The application of the 15N and 13C labelled version of the peptides would enable to demonstrate the presence and
distinguish between inter- and intramolecular H-bonds [12], thus to reveal the structure of self-assemblies or even
coaggregates of peptides and membrane mimicking detergent micelles/bicelles at high resolution. Such experiments
could take us one step closer to the revelation of the structure–function relationship of CLPs. As the recent efforts had
shown, growing viscosinamide-producer Pseudomonas sp. DR54 in a minimal salt medium prepared by the addition of
15NH4Cl successfully yielded the
15N-enriched biomolecules in interest, so this method is planned to be accomplished the
isotopical labelling of other CLPs as well.
Conclusion
By systematically studying the effect of the total peptide chain and/or ring residue number on the overall
conformation, we can conclude that the amphipathic character is a crucial factor in the design of natural CLPs,
irrespectively of the exact amino acid composition. The 15N and 13C labelled lipopeptides will make the direct
identification of intra- and intermolecular H-bonds in self-assemblies/peptide–detergent coaggregates feasible,
thus bring more details to light about the mode of action behind the versatile bioactivity of these biomolecules.
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Figure 2: The tertiary structures of
the scrutinized CLPs. In the bottom
right corners the amphipathic
character is emphasized by coloring
the whole side chains according to
their polarity. For better overview,
the fatty acid part is omitted. The
experimental conditions and the
software(s)/force field(s) used for
the structure calculations are also
indicated.
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Figure 3: Top: the proposed model for
the self-assembly based on diffusion
measurements (adapted from [10]).
Bottom: the peaks in the 1H spectrum
of pseudodesmin A dissolved in CDCl3
(15 mM) care uniformly broadened due
to the hindered rotational diffusion.
Here, only the aliphatic region is
displayed. The translational diffusion
constant measured for the assembly
(Dt, 1H) and the hypothetical value for a
monomer (Dt, m) are also displayed.
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